HDAC6 and androgen insensitivity syndrome: Similarly, none of the included studies investigated whether HDAC6 inhibition provided protection against other aspects of AIS pathophysiology, such as blood-brain-barrier destabilisation,34 meaning that the understanding of the mechanisms underpinning the apparent benefits of HDAC6 inhibition is incomplete.